Hexagon Nutrition IPO Day 4: GMP ₹10
Alright folks, we’re at the cusp of the final day for the Hexagon Nutrition IPO, and it’s Day 4 already! The clock is ticking towards the June 9th closing deadline, and many of you are probably wondering how things are shaping up. As of today, the subscription numbers are still showing zero across all categories – Retail, NII, and QIB. While this might sound alarming at first glance, let’s dive deeper into what this actually means and what the Grey Market Premium (GMP) is telling us.
| Date | GMP | Est. Listing |
|---|---|---|
| 06 Jun | +₹9 | ₹54 |
| 05 Jun | +₹10 | ₹55 |
Subscription Status
The fact that we’re seeing 0x subscription across the board on Day 4 is, frankly, quite unusual for a Mainboard IPO on the NSE. Typically, by this stage, we’d expect to see at least some initial traction, especially from the retail segment. This lack of immediate subscription could indicate a few things. It might be that investors are waiting for the last-minute rush, a common strategy for some, or perhaps the issue hasn’t quite captured the market’s immediate attention. The absence of QIB (Qualified Institutional Buyer) and NII (Non-Institutional Investor) subscriptions is also noteworthy. These are usually the first to show interest if they’re confident about the company’s prospects. Their silence so far could mean they’re conducting their due diligence or are adopting a wait-and-watch approach. The lot size for Hexagon Nutrition is 333 shares, and the issue price is set at ₹42, making each lot worth ₹13,986 for retail investors.
GMP Update
Now, let’s talk about the Grey Market Premium (GMP). The current GMP for Hexagon Nutrition IPO stands at ₹10. This is exactly where it was yesterday, indicating a stable sentiment in the unlisted market. A GMP of ₹10 over the issue price of ₹42 means the expected listing price is around ₹52. This suggests a potential listing gain of about 23.8%. While a ₹10 GMP isn’t a massive surge, it’s positive and shows that there’s still a decent appetite for the stock, even if it hasn’t translated into immediate subscription numbers yet. The stability of the GMP is encouraging; it hasn’t dipped, which is a good sign. However, remember, GMP is an unofficial indicator and can be volatile. It doesn’t guarantee listing gains.
Should You Apply?
So, the big question: to apply or not to apply? The subscription data, or rather the lack thereof, is a bit of a puzzle. It’s atypical, and that’s something to consider. However, the GMP is holding steady at ₹10, pointing towards a modest listing gain. This presents a balanced view. For those who believe in the long-term prospects of Hexagon Nutrition and are comfortable with a potential listing gain, the current situation might offer an opportunity to apply without facing intense oversubscription on the final day. On the other hand, if you’re someone who prefers to see strong subscription figures before committing, you might want to hold back. As always, it’s crucial to do your own research. SEBI registered investment advisors can offer further insights tailored to your risk profile.